BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PBEvsSLTYETF Comparison

ETF 1

PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of

BioTech & Genomics

-0.14%

Full PBE fund page

VS

ETF 2

SLTY

YieldMax Ultra Short Option Income Strategy ETF

This fund is part of

Alternatives

-0.34%

Full SLTY fund page

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. YieldMax Ultra Short Option Income Strategy ETF (SLTY) is part of the Alternatives segment. PBE's top 3 sector exposures are and Health Care. In contrast, SLTY's top sector exposures are and Consumer Discretionary.Communication Services, Industrials, PBE is less expensive with a Total Expense Ratio (TER) of 0.58%, versus 1.24% for SLTY. PBE is down -3.02% year-to-date (YTD) with -$4M in YTD flows. SLTY performs worse with -4.29% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of PBE and SLTY below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PBE vs SLTY performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 04/28/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PBE SLTY	+3.54%-6.31%	-3.31%+4.78%	-3.02%-4.29%	+30.84%n/a	+28.68%n/a	+4.30%n/a
Flows	PBE SLTY	+$18K+$3M	-$8M+$6M	-$4M+$3M	-$32M-	-$60M-	-$44M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PBE SLTY	+19.47%+13.82%	+19.83%n/a	+20.12%n/a	+22.54%n/a
Max drawdown	PBE SLTY	-9.36%-8.17%	-11.70%n/a	-22.21%n/a	-34.74%n/a
Max drawdown duration	PBE SLTY	79d29d	111dn/a	324dn/a	1540dn/a

Trading data

Create an account to view trading data

Join for free

	PBE	SLTY
Last sale 4/28/2026 at 7:55 PM	$79.59	$26.26
Previous close 04/28/2026	$79.93	$26.62
Consolidated volume 04/28/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of March 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

SLTY

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	PBE	SLTY
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 4/28/2026 at 7:55 PM

Live

Closed

	PBE	SLTY
Last price	$79.59	$26.26
1D performance	-0.43%	-1.37%
AuM	$247.37 M	$19.96 M
E/R	0.58%	1.24%

Characteristics

	PBE	SLTY
Management strategy	Passive	Active
Provider	Invesco	YieldMax ETFs
Benchmark	Dynamic Biotech & Genome Intellidex Index	-
N° of holdings	30	24
Asset class	Equities	-
Trailing 12m distribution yield	Join	Join
Inception date	June 23, 2005	August 21, 2025
ESG	No	No

More PBE data on Trackinsight

More SLTY data on Trackinsight

Exposure

Countries

PBE

USA

92.18%

Other

7.82%

SLTY

Data will be available soon

Sectors

PBE

Health Care

97.59%

Other

2.41%

SLTY

Data will be available soon

Diversification

PBE

Total weight of top 15 holdings out of 15

63.66%

SLTY

Data will be available soon

Top 15 holdings

Data as of March 31, 2026

PBE

UTD THERAPEUT

6.05%

ILLUMINA

5.24%

REGENERON PHARMACEUTICALS

5.23%

ALNYLAM PHARMACEUTICALS

5.22%

BIOGEN INC

5.16%

AMGEN-T

4.99%

GILEAD SCIENCES

4.98%

INCYTE

4.89%

BIOCRYST PHARMACEUTICALS

3.66%

PROTAGONIST THERAPEUTICS INC

3.38%

TG THERAPEUTICS

3.11%

ROYALTY PHARMA

3.05%

NEUROCRINE BIOSCIENCES

2.93%

CATALYST PHARMACEUTICALS INC

2.89%

PTC THERAPEUTI/D

2.86%

SLTY

Data will be available soon

Frequently asked questions about PBE and SLTY

How have the PBE and SLTY ETFs performed in 2026?

As of April 28, 2026, PBE is down -3.02% year-to-date (YTD), while SLTY has lost -4.29%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or SLTY?

Year-to-date, the PBE ETF saw -$4M in flows, compared to +$3M for SLTY.

Which ETF is bigger: PBE or SLTY?

As of April 28, 2026, PBE holds $247.37 M in assets under management (AUM), while SLTY manages $19.96 M.

What are the top holdings of the PBE ETF and SLTY ETF?

PBE top holdings include UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS. SLTY holds in its top three: US912797RG48, US912797RF64 and US912797RS85.

PBEvsSLTYETF Comparison

Invesco Dynamic Biotechnology & Genome ETF

YieldMax Ultra Short Option Income Strategy ETF

PBE vs SLTY performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PBE and SLTY ETFs performed in 2026?

As of April 28, 2026, PBE is down -3.02% year-to-date (YTD), while SLTY has lost -4.29%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or SLTY?

Year-to-date, the PBE ETF saw -$4M in flows, compared to +$3M for SLTY.

Which ETF is bigger: PBE or SLTY?

As of April 28, 2026, PBE holds $247.37 M in assets under management (AUM), while SLTY manages $19.96 M.

What are the top holdings of the PBE ETF and SLTY ETF?

PBE top holdings include UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS. SLTY holds in its top three: US912797RG48, US912797RF64 and US912797RS85.

Which ETF is more diversified: PBE or SLTY?

PBE holds 30 securities with 63.66% of its assets in the top 15. SLTY has 30 securities and a top 15 weight of 51.67%.

Calamos Investments Powers the Next Phase of the Autocallable Revolution